• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tevogen Bio Holdings Inc. - Common Stock (NQ: TVGN )

    1.140 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 166,514
    Open 1.140
    Bid (Size) 1.180 (31)
    Ask (Size) 1.190 (17)
    Prev. Close 1.140
    Today's Range 1.140 - 1.140
    52wk Range 0.2556 - 21.09
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company’s Novel Business Model as Key to Sustainable Success through Patient Affordability
    From Tevogen Bio Inc
    Via GlobeNewswire
    Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920
    From Tevogen Bio Inc
    Via GlobeNewswire

    Performance

    YTD
    -88.60%
    -88.60%
    1 Month
    +263.17%
    +263.17%
    3 Month
    +85.67%
    +85.67%
    6 Month
    +14.99%
    +14.99%
    1 Year
    -88.60%
    -88.60%

    More News

    Read More
    Tevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient Support
    From Tevogen Bio Inc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    EXCLUSIVE: Top 20 Most-Searched Tickers On Benzinga Pro In October 2024 — Where Do Tesla, Nvidia, Apple, DJT Stock Rank?
    Via Benzinga
    Topics Government
    Exposures Political
    Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs
    From Tevogen Bio Inc
    Via GlobeNewswire
    Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company
    From Tevogen Bio Inc
    Via GlobeNewswire
    Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity
    From Tevogen Bio Inc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Philips Posts Weak Earnings, Joins Clear Channel Outdoor And Other Big Stocks Moving Lower In Monday's Pre-Market Session
    Via Benzinga
    Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Tevogen Bio Provides Additional Guidance on Introduction of T Cell Therapy for Oncology and Specialty Care Therapeutic Areas
    From Tevogen Bio Inc
    Via GlobeNewswire
    Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    Early Movers: PRSO, TVGN, ZENA, CCTG, CRDL Stocks to Watch Today!
    Via AB Newswire
    Topics Artificial Intelligence Intellectual Property
    Exposures Artificial Intelligence Intellectual Property
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Tevogen Bio Shares Are Soaring Wednesday: What's Going On?
    Via Benzinga
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Tevogen Bio’s Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development
    From Tevogen Bio Inc
    Via GlobeNewswire
    Tevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This Week
    From Tevogen Bio Inc
    Via GlobeNewswire
    Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion
    From Tevogen Bio Inc
    Via GlobeNewswire
    Tevogen Bio Provides Clarity on CSO Share Sales to Satisfy Tax Obligations, Expects Additional Forecast and Progress Updates in the Coming Days
    From Tevogen Bio Inc
    Via GlobeNewswire
    Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days
    From Tevogen Bio Inc
    Via GlobeNewswire
    12 Health Care Stocks Moving In Friday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.